App
Moneycontrol App Android App iOS App iPad App Android Tab Blackberry Windows App Windows Tab
Subscription
Specials
Stocks
Feedback
Log In
Sign Up
Moneycontrol
Get App
Select Language
Subscription
Specials
Close Ad
SENSEX NIFTY
you are here:

Markets

Live TV
NIFTY 50
9979.10
152.95 (1.56%)
SENSEX
33825.53
522.01 (1.57%)

Ranbaxy Laboratories Ltd.

BSE: 500359 | NSE: RANBAXY | Series: NA | ISIN: INE015A01028 | SECTOR: Pharmaceuticals

| BSE 859.90 0.00 (0.00%) | |

BSE Live

Apr 01, 16:00
859.90 0.00 (0.00%)
Volume
No Data Available
308,222

  • Prev. Close

    859.90

  • Open Price

    814.90

810.30

Today’s L/H

869.00
414.40

52 Wk L/H

869.00
732.70

L/U Price Band

895.50

  • Bid Price (Qty.)

    0.00 (0)

  • Offer Price (Qty.)

    0.00 (0)

  •  VWAP

    844.65
     Beta
    0.37
  •  Market Depth
    BUY 0.00
    SELL 0.00
    0%
    0%
Ranbaxy Laboratories is not traded on BSE in the last 30 days

NSE Live

Apr 01, 15:59
859.80 0.00 (0.00%)
Volume
No Data Available
5,415,702

  • Prev. Close

    859.80

  • Open Price

    814.70

809.45

Today’s L/H

869.70
371.50

52 Wk L/H

869.70
33.25

L/U Price Band

36.75

  • Bid Price (Qty.)

    0.00 (0)

  • Offer Price (Qty.)

    859.80 (9924)

  •  VWAP

    847.00
     Beta
    0.39
  • DELIVERY AVERAGES
    3-Day
    43.73%
    5-Day
    48.62%
    8-Day
    51.80%
    Deliverables
    43.73%
  • SMA
    30
    50
    150
    200
    SMA
Ranbaxy Laboratories is not traded on NSE in the last 30 days

Charts

  • Open : -
  • High : -
  • Low -
  • Close: -
  • Volume -

TECHNICAL ANALYSIS

TECHNICAL RATING
Very Bullish
Moving Averages Bullish
Technical Indicators Bullish
Moving Averages Crossovers Bullish
See Detail
Pivot levels
Type R1 R2 R3 PP S1 S2 S3
Classic 883.18 906.57 943.43 846.32 822.93 786.07 762.68
Fibonacci 869.33 883.55 906.57 846.32 823.30 809.08 786.07
Camarilla 865.32 870.85 876.37 846.32 854.28 848.75 843.23

Note : Support and Resistance level for the day, calculated based on price range of the previous trading day.

SIMPLE MOVING AVERAGES
Days NSE
5 820.99
10 819.28
20 812.30
50 749.31
100 689.90
200 633.68
Get Historical Prices
Pivot levels

Note : Support and Resistance level for the day, calculated based on price range of the previous trading day.

Pivot levels
Type R1 R2 R3 PP S1 S2 S3
Classic 889.63 919.47 969.23 839.87 810.03 760.27 730.43
Fibonacci 870.27 889.06 919.47 839.87 809.46 790.67 760.27
Camarilla 867.10 874.39 881.69 839.87 852.50 845.21 837.91

Note : Support and Resistance level for the week, calculated based on price range of the previous trading week.

SIMPLE MOVING AVERAGES
Pivot levels

Note : Support and Resistance level for the week, calculated based on price range of the previous trading week.

Pivot levels
Type R1 R2 R3 PP S1 S2 S3
Classic 883.18 906.57 943.43 846.32 822.93 786.07 762.68
Fibonacci 869.33 883.55 906.57 846.32 823.30 809.08 786.07
Camarilla 865.32 870.85 876.37 846.32 854.28 848.75 843.23

Note : Support and Resistance level for the month, calculated based on price range of the previous trading month.

SIMPLE MOVING AVERAGES
Pivot levels

Note : Support and Resistance level for the month, calculated based on price range of the previous trading month.

Valuation

    • Market Cap (Rs Cr.)
      36,602.80
    • P/E
      -
    • Book Value (Rs)
      25.79
    • Dividend (%)
      0.00
    • Market Lot
      1
    • Industry P/E
      31.17
    • EPS (TTM)
      -
    • P/C
      253.63
    • Price/Book
      33.34
    • Dividend Yield.(%)
      -
    • Face Value (RS)
      5.00
    • Deliverables (%)
      DELIVERY AVERAGES (%)
      3-Day
      43.73
      5-Day
      48.62
      8-Day
      51.80
      41.95

* Note - P.E (TTM) is displayed only when latest 4 quarter results are positive.

    • Market Cap (Rs Cr.)
      36,602.80
    • P/E
      -
    • Book Value (Rs)
      77.61
    • Dividend (%)
      0.00
    • Market Lot
      1
    • Industry P/E
      31.17
    • EPS (TTM)
      -
    • P/C
      -
    • Price/Book
      11.08
    • Dividend Yield.(%)
      -
    • Face Value (RS)
      5.00
    • Deliverables (%)
      DELIVERY AVERAGES (%)
      3-Day
      43.73
      5-Day
      48.62
      8-Day
      51.80
      41.95

* Note - P.E (TTM) is displayed only when latest 4 quarter results are positive.

Forum

Community Sentiments

Data not Available

What's your call on today?

Read 0 investor views

BUY SELL HOLD
POST

Action in Ranbaxy Laboratories Ltd.

News & Videos

You are man of honour, come with viable plan to pay Daiichi: Delhi HC to Shivinder Singh

You are man of honour, come with viable plan to pay Daiichi: Delhi HC to Shivinder Singh

Business | Earnings | Management Interviews
View More

News across the web

Announcements

View More

Pre-Opening Session Prices9:00 am - 9:15 am

BSE

Jun 02, 09:15
814.90 -45.00 (-5.23%)
High 814.90
Low
Prev. Close 859.90

NSE

Jun 02, 09:15
814.70 -45.10 (-5.25%)
High 814.70
Low
Prev. Close 859.80

Financials

(Rs. Cr)
(Rs. Cr)
Quarterly | Half Yearly | Nine Months | Annual
Quarterly DEC 2014 SEP 2014 JUN 2014 MAR 2014 DEC 2013
Sales
2,618.85 3,260.49 2,426.26 2,466.82 2,893.99
Other Income
10.68 17.39 25.45 23.70 35.24
Total Income
2,629.53 3,277.88 2,451.71 2,490.52 2,929.23
Total Expenditure
2,618.00 2,577.29 2,501.81 2,347.30 2,869.01
EBIT
11.52 700.59 -50.12 143.22 60.22
Interest
146.94 137.28 142.35 113.57 120.57
Tax
888.19 85.14 -5.59 109.86 98.14
Net Profit
-1,023.61 478.17 -186.88 -80.21 -158.49
Profit & Loss Nine Months Results Half Yearly Results Quarterly Results
(Rs. Cr)
(Rs. Cr)
Profit & Loss Nine Months Results Half Yearly Results Quarterly Results

Historical Prices

On
 Current Price %Gain / Loss
No Record Found
On
 Current Price %Gain / Loss
No Record Found
Click Here to view the Open, High, Low, Close, Volume and Historic data for
Index Price Change %Chg
NIFTY 50 9979.10 152.95 1.56
SENSEX 33825.53 522.01 1.57
NIFTY BANK 20530.20 570.30 2.86
NIFTY IT 14422.40 115.30 0.81
S&P BSE Smallcap 11428.41 205.65 1.83
View More
Index Price Change %Chg
DAX (Jun 02) 12,039.35 452.50 3.91
CAC (Jun 02) 4,863.60 100.82 2.12
FTSE (Jun 02) 6,227.33 60.91 0.99
Straits Times (Jun 02) 2,611.63 60.77 2.38
SGX Nifty (Jun 02) 9,958.00 -21.00 -0.21
View More

CORPORATE ACTION

Date Agenda
No Board Meetings Information is available for Ranbaxy Laboratories
View More
Type Dividend% Ex-Dividend date
Final 40.00 Apr 28, 2011
Final 120.00 May 21, 2008
Interim 50.00 Nov 01, 2007
Interim 120.00 Apr 04, 2007
Interim 50.00 Nov 02, 2006
View More
Ratio Announcement Date Ex-Bonus
3:5 Jul 18, 2002 Oct 01, 2002
1:1 Nov 11, 1998 Dec 01, 1998
1:2 Mar 30, 1993 Apr 23, 1993
2:3 Sep 30, 1991 Oct 18, 1991
2:5 Jul 02, 1988 -
View More
Old FV New FV Ex-Split
10 5 Jul 25, 2005
View More
Ratio Premium Ex-Bonus
9:100 0 Oct 18, 1991
View More
Date Agenda
Sep 19, 2014 -
Jul 28, 2014 -
May 07, 2013 -
May 08, 2012 -
May 09, 2011 Rs.2.00 per share(40%)Dividend
View More

Dividend Summary

Ranbaxy Laboratories has not declared any dividend for the last several years. As per the Profit & Loss account

SHARE HOLDING PATTERN & MUTUAL FUND HOLDING

Share Holding Pattern in (%)

Standalone September 2014 June 2014 March 2014 December 2013
Promoters 63.37 63.4 63.41 63.41
Pledged 0 0 0 0
FII/FPI 13.08 12.42 11.79 10.74
Total DII 12.57 12.02 10.75 12.68
Fin.Insts 0.07 0.22 0.38 0.29
Insurance Co 7.12 7.4 7.45 7.57
MF 1.22 0.49 0.47 0.95
Others DIIs 4.16 3.91 2.45 3.87
Others 10.99 12.16 14.06 13.17
Total 100.01 100 100.01 100

Mutual Funds Holding

Data not available

PEERS COMPARISON

Company Name Last Price % Change 52 Wk High 52 Wk Low Market Cap Sales Qtr Net Profit Qtr
ABB Power Produ 833.95 0.72 854.90 749.70 3534.42 3,230.74 165.39
Affle India 1515.00 -1.75 2296.00 745.00 3862.7 182.23 32.89
Gujarat Fluoro 300.90 0.18 900.00 0.00 3305.39 -- -0.01
Nivaka Fashions 10.20 0.00 12.84 0.00 104.74 -- --
Gensol Engineer 84.90 0.00 89.50 77.50 69.64 -- --

COMPANY OVERVIEW

Ranbaxy Laboratories Ltd. is pharmaceutical company. It develops, manufactures and markets generic, branded generic, over-the-counter products, anti-retrovirals, active pharmaceutical ingredients and intermediates. Its products include simvastatin, amoxyclav potassium, isotretinion, ciprofloxacin, isotretinon, cephalexin, ketorolac tromethamine, cefaclor, clarithromycin and cefuroxime axetil. The company was founded in 1961 and is based in Gurgaon, Haryana. Ranbaxy Laboratories Ltd. operates as a subsidiary of Daiichi Sankyo Company Ltd.

COMPANY INFORMATION

  • Registered Office

  • Registrars

    • Name

      Alankit Assignment Ltd.

    • Address

      Jhandewalan Extension

    • City

      New Delhi 110055

    • State

      Delhi

    • Tel. No.

      011-23541234, 42541234

    • Fax No.

      011-42541201, 51540064

    • Email

      info@alankit.com

    • Internet

      http://www.alankit.com

  • Management

    • Name

      Designation

    • Tsutomu Une

      Chairman

    • Arun Sawhney

      Managing Director & CEO

    • Akihiro Watanabe

      Director

    • Anthony H Wild

      Director

    • Kazunori Hirokawa

      Director

  • Listing

    Whether The Company Forms A Part Of The Following Indices -
    • Sensex

      No

    • Nifty

      No

    • Bse-100

      No

    • Bse-200

      No

    • S&P CNX 500

      No

    • CNX Midcap

      No

About Ranbaxy Laboratories Ltd.

Ranbaxy Labs is in the Pharmaceuticals sector.

It is listed on the BSE with a BSE Code of 500359 and the NSE with an NSE Code of RANBAXY.

Quick links

News

Corporate Action

Information

Financials

Annual Report

Peer Comparison

Related Searches

Ranbaxy Laboratories Stock Price | Ranbaxy Labs Stock Quote | Ranbaxy Labs Results | Ranbaxy Labs News | View All Related Searches
Sections
Desktop Version »
Follow us on
Facebook Twitter Instagram
Available On
Download from Google Play Download from App Stoer Download from Windows Phone
Disclaimer | Terms & Conditions | Privacy Policy | Cookie Policy | FAQs | Sitemap | Feedback
Network 18 Sites: News18 | Firstpost | CNBC TV18 | In.com | Cricketnext | Overdrive | Topper Learning

Copyright © e-Eighteen.com Ltd All rights resderved. Reproduction of news articles, photos, videos or any other content in whole or in part in any form or medium without express writtern permission of moneycontrol.com is prohibited.